Product Program year 2025 Source: CMS Open Payments

Serrantor

Device Pno

Open in the dashboard

General payments

$776,552

2,936 payments

Research payments

$254,426

27 payments

Through program year 2025, $776,552 in general payments and $254,426 in research payments were reported against Serrantor (Pno).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $468,673 1,494
2025 Research $254,426 27
2024 General $103,463 590
2023 General $82,556 514
2022 General $121,861 338

Breakdown

Who paid General payments · program years 2022–2025
  1. Cagent Vascular LLC $776,552 2,936 payments
Top recipients General payments · program year 2025
  1. Peter Schneider Vascular Surgery · Honolulu, HI $60,938 13% · 16 payments
  2. Neil Poulsen Vascular Surgery · Rockaway, NJ $55,860 12% · 41 payments
  3. Antonis Pratsos Interventional Cardiology · Broomall, PA $44,007 9% · 19 payments
  4. Andre Cole Vascular Surgery · Vineland, NJ $19,566 4% · 17 payments
  5. Deepika Kalisetti Interventional Cardiology · Scranton, PA $18,754 4% · 15 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Vascular Surgery Surgery $282,662 60% · 206 practitioners
  2. Interventional Cardiology Internal Medicine $113,841 24% · 75 practitioners
  3. Vascular & Interventional Radiology Radiology $26,492 6% · 31 practitioners
  4. Cardiovascular Disease Internal Medicine $21,683 5% · 47 practitioners
  5. Hospitalist $5,618 1% · 2 practitioners

The top 5 of 33 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New Jersey $128,813 27% · 41 recipients
  2. Pennsylvania $94,991 20% · 26 recipients
  3. Texas $63,625 14% · 78 recipients
  4. Hawaii $61,057 13% · 2 recipients
  5. New York $22,774 5% · 46 recipients

The top 5 of 40 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

2,936 general · 27 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record